Specific binding sites for synthetic growth hormone secretagogues in non-tumoral and neoplastic human thyroid tissue

Journal of Endocrinology

Volumn 165, Issue 1, 2000, Pages 139-146

  Cassoni, P ^a   Papotti, M ^a   Catapano, F ^a   Ghe C ^a   Deghenghi, R ^c   Ghigo, E ^b   Muccioli, G ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c Ardana   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GROWTH HORMONE; HEXARELIN; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; IBUTAMOREN; TYROSINE;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL PROLIFERATION; CONTROLLED STUDY; FOLLICULAR CARCINOMA; HORMONE ACTION; HORMONE BINDING; HORMONE INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; THYROID CANCER; THYROID GLAND;

EID: 0034036958     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1650139     Document Type: Article

References (29)

1. Arvat E, Di Vito L, Lanfranco F, Broglio F, Giordano R, Benso A, Muccioli G, Deghenghi R & Ghigo E 1999 Tyr-Ala-hexarelin, a synthetic octapeptide, possess the same endocrine activities of hexarelin and GHRP2 in humans. Journal of Endocrinological Investigation 22 91-97.
2. Berti F, Müller E, De Gennaro Colonna V & Rossoni G 1998 Hexarelin exhibits protective activity against cardiac ischemia in hearts from growth hormone-deficient rats. Growth Hormone and IGF Research 8 149-152.
3. Bisi G, Podio V, Valetto MR, Broglio F, Bertuccio G, Del Rio G, Arvat E, Boghen MF, Deghenghi R, Muccioli G, Ong H & Ghigo E 1999 Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans. Journal of Endocrinological Investigation 22 266-272.
4. Bowers CY 1998 Growth hormone-releasing peptides. Cellular and Molecular Life Sciences 54 1316-1329.
5. Camanni F, Ghigo E & Arvat E 1998 Growth hormone-releasing peptides and their analogs. Frontiers in Neuroendocrinology 19 47-72.
6. Casanueva F & Dieguez C 1999 Growth hormone secretagogues: physiological role and clinical utility. Trends in Endocrinology and Metabolism 10 30-38.
7. Deghenghi R 1998 Structural requirements of growth hormone secretagogues. In Growth Hormone Secretagogues in Clinical Practice, pp 27-35. Eds B B Bercu & R F Walker. New York: Marcel Dekker.
8. Deghenghi R, Boutignon F, Muccioli G, Ghigo E & Locatelli V 1999 Impervious peptides as growth hormone secretagogues. In Peptide Science -Present and Future, pp 411-412. Ed Y Shimonishi. Kluwer: Academic Publishers.
9. Desaphy J-F, De Luca A, Piemo S, Imbrici P & Conte Camerino D 1998 Partial recovery of skeletal muscle sodium channel properties in aged rats chronically treated with growth hormone or the GH secretagogue hexarelin. Journal of Pharmacology and Experimental Therapeutics 286 903-912.
10. Estour B, Van Herle AJ, Juillard GJ, Totanes TL, Sparkes RS, Giuliano AE & Klandorf H 1989 Characterization of a human follicular thyroid carcinoma cell line (UCLA RO W-1). Virchows Archiv. B. Cell Pathology 57 167-174.
11. Ghigo E, Arvat E, Muccioli G & Camanni F 1997 Growth hormone-releasing peptides. European Journal of Endocrinology 136 445-460.
12. Guan XM, Yu H, Palyha OC, McKee K-K, Feighner SD, Sirinathsinghji DJS, Smith RG, Van der Ploeg LH & Howard AD 1997 Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Research, Molecular Brain Research 48 23-29.
13. Hedinger C, Williams ED & Sobin LH 1988 Hystological Typing of Thyroid Tumours: International Hystological Classification of Tumours, edn 2. Geneva: WHO.
14. Howard HD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee K, Pong S-S, Chaung L-Y, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJS, Dean DC, Melillo DG, Patchett AA, Nargund R, Griffin PR, DeMartino JA, Gupta SK, Schaeffer JM, Smith RG & Van der Ploeg LHT 1996 A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273 974-976.
15. Isgaard J, Tivesten A, Bollano E, Kujacic V, Caidahl K, Sun XY, Hedner T, Hjalmarson A & Bengtsson B-A 1998 The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction. IV European Congress of Endocrinology, OR3-7. Bristol: Bioscientifica.
16. McKee K, Tan CP, Palyha OC, Liu J, Feighner SD, Hreniuk DL, Smith RG, Howard AD & Van der Ploeg LHT 1997 Cloning and characterization of two human G protein coupled receptor genes (GPR38 and GPR39) related to growth hormone secretagogue and neurotensin receptors. Genomics 46 426-434.
17. Mato E, Matias-Guiu X, Chico A, Webb SM, Cabezas R, Berna L & De Leiva A 1998 Somatostatin and somatostatin receptor subtype gene expression in medullary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 83 2417-2420.
18. Muccioli G, Ghè C, Faccani G, Lanotte M, Forni M & Ciccarelli E 1997a Prolactin receptors in human meningiomas: characterization and biological role. Journal of Endocrinology 153 365-371.
19. Muccioli G, Ghè C, Ghigo MC, Papotti M, Arvat E, Boghen MF, Nilsson MHL, Deghenghi R, Ong H & Ghigo E 1997b GHRP receptors in pituitary, central nervous system and peripheral human tissues. Journal of Endocrinological Investigation 20 (suppl 4) 52 (Abstract).
20. Muccioli C, Ghè C, Ghigo MC, Papotti M, Arvat E, Boghen MF, Nilsson MHL, Deghenghi R, Ong H & Ghigo E 1998 Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland. Journal of Endocrinology 157 99-106.
21. Muccioli G, Broglio F, Valetto MR, Ghè C, Catapano F, Graziani A, Papotti M, Bisi G, Deghenghi R, & Ghigo E 2000 Growth hormone-releasing peptides and the cardiovascular system. Annales d' Endocrinologie (In Press).
22. Ong H, Bodart V, McNicoll N, Lamotagne D & Bouchard JF 1998a Binding sites for growth hormone-releasing peptide. Growth Hormone and IGF Research 8 137-140.
23. Ong H, McNicoll N, Escher E, Collu R, Deghenghi R, Locatelli V, Ghigo E, Muccioli G, Boghen M & Nilsson M 1998b Identification of a pituitary GHRP receptor subtype by the photoaffinity labeling approach. Endocrinology 139 432-435.
24. Pang XJ, Hershman M, Chung M & Pekary AE 1989 Characterization of tumor necrosis fictor-α receptors in human and rat thyroid cells and regulation of the receptors by thyrotropin. Endocrinology 125 1783-1788.
25. Pong S-S, Chaung L-Y, Dean DC, Nargund R, Patchett AA & Smith RG 1996 Identification of a new G-protein-linked receptor for growth hormone secretagogues. Molecular Endocrinology 10 57-61.
26. Reubi JC, Chayvialle A, Franc B, Cohen R, Calmettes C & Modigliani E 1991 Somatostatin receptors and somatostatin content in medullary thyroid carcinomas. Laboratory Investigation 64 567-573.
27. Scatchard G 1949 The attraction of proteins for small molecules and ions. Annals of the New York Academy of Sciences 51 660-672.
28. Smith RG, Van der Ploeg LHT, Howard AD, Feighner SD, Cheng K, Hickey GJ, Wyvratt MJ, Fisher MH, Nargund RP & Patchett AA 1997 Peptidomimetic regulation of growth hormone secretion. Endocrine Reviews 18 621-645.
29. Tan CP, McKee K-K, Liu Q, Palyha OC, Feighner SD, Hreniuk DL, Smith RG & Howard AD 1998 Cloning and characterization of a human and murine T-cell orphan G-protein-coupled receptor similar to the growth hormone secretagogue and neurotensin receptors. Genomics 52 223-229.